http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-598121-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5f8977e07a3e94324d170e6373e9564
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
filingDate 2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66ab58a504527cf1b1ecf4ace74943f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a72819fe9854226646d9e3b29a4b095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9365ec0b9b93ce9066d226f275a60a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bfee96475372ade4a46ae2444776cfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1627dd236e3a8019c5ad7761ebb4cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405f5330fb5a72896ec98a37f9d9a7a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ec056ba471393cf2e55128ef13c3acf
publicationDate 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-598121-A
titleOfInvention Nitroimidazooxazines and their uses in anti-tubercular therapy
abstract 598121 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof in the treatment of microbial infection. Embodiments of the compound include: (6S)-6-{ [2'-chloro-4'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]methoxy} -2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, (6S)-2-nitro-6-({ 4-[4-(trifluoromethoxy)benzyl]benzyl} oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, and (6S)-2-Nitro-6-[(6-{ [4-(trifluoromethoxy)phenyl]ethynyl} -3-pyridinyl)methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine.
priorityDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413591137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413590293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50916525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44627113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413590243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413371767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66707439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50916697

Total number of triples: 34.